Pricing Log in Create free account
Saturday 17 October 2026 Export OFIX’s income statement to Excel — free account

ORTHOFIX MEDICAL INC.

OFIX Healthcare Medical Devices

ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024. In the quarter to June 2026, revenue grew 3.85%, EPS fell 8.33%, free cash flow fell 516.6% and total debt rose 34.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

9.38 0.21 −2.19%
Market cap
$390.6M
P/E
0.0×
Fwd P/E
−8.5×
Dividend yield
—
F-score
5/9
Altman Z
1.29
Beneish M
−3.19
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 6.82
Total sells 6.60
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — 1 1 — 2 — — — 1 —
Sell — — 2 — 8 1 1 1 — 2 1 1
Insider Ownership 1.63%

Capital & Financial Ratios $m

Market Cap 390.63
Revenue 833.19
Net Income (61.72)
Free Cash Flow (27.82)
Net Debt 130.09
Current Ratio 2.84 (at or above 1.5: strong)
Debt/Equity 0.55
P/E ratio 0.00
Fwd P/E (8.47) (negative: loss-making)
P/S ratio 0.46
P/B ratio 0.89
Past 5Y EPS Growth —
This Y EPS Growth 49.57% (at or above 15%: strong)
Next Y EPS Growth 19.57% (at or above 15%: strong)
Next Y revenue growth 3.49%
Next 5Y EPS Growth 35.00% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.6×, against a ten-year median of 1.4×; over the ten years it ranged from 0.6× in 2026 to 2.5× in 2018.
P/S against its own 10 years 1.40%
10-year low 10-year high
P/B against its own 10 years 7.96%
10-year low 10-year high
EV/Sales against its own 10 years 2.54%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 38 86 85 104
Receivables 128 135 136 136
Inventory 222 189 172 184
Other — — — —
420 433 417 446
2023 2024 2025 Q'26
Payables 58 49 58 64
ST’ Debt 1 — — —
Other 105 119 111 93
165 169 170 157

Compound Annual Growth %

10y 5y 3y
Sales 7.57% 15.13% 21.30%
Cash Flow (2.65%) (14.80%) 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 4.48% 4.75% 10.14%

Revenue $m

Mar Jun Sep Dec Year
’26 197 211 — — —
’25 194 203 206 220 822
’24 189 199 197 216 799
’23 175 187 184 200 747
’22 106 118 114 122 461
’21 106 121 112 125 464
’20 105 73 111 118 407
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (18) (6) — — —
’25 (18) 12 12 28 33
’24 (19) 9 12 24 26
’23 (34) (6) 0 (7) (46)
’22 (8) (5) (1) 2 (12)
’21 2 (2) 6 12 18
’20 12 18 22 22 74
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (28) (19) — — —
’25 (25) 5 2 17 (1)
’24 (29) (1) 6 15 (9)
’23 (46) (18) (23) (22) (108)
’22 (14) (13) (6) (4) (35)
’21 (3) (8) 3 4 (1)
’20 6 13 19 10 50
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.52) (0.39) — — —
’25 (1.35) (0.36) (0.57) (0.06) (2.33)
’24 (0.95) (0.88) (0.71) (0.75) (3.30)
’23 (1.71) (1.07) (0.77) (0.59) (4.12)
’22 (0.22) 0.12 (0.53) (0.35) (0.98)
’21 (0.30) 0.12 (0.11) (1.65) (1.95)
’20 1.32 (0.96) 0.24 (0.48) 0.13
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 32.51 33.51 48.00 39.75 22.11 28.65 13.76 9.57 12.08 10.24

Analyst estimates 2026–2028

Powerpack
High 48.25 56.53 63.57 74.44 47.91 48.50 36.13 23.19 20.73 20.48
People
People Employees 938 858 954 1,055 1,036 1,087 1,092 1,634 1,616 1,605
Revenue/emp, $m 0.44 0.51 0.47 0.44 0.39 0.43 0.42 0.46 0.49 0.51
Income, $m
Income, $m Revenue 410 434 453 460 407 464 461 747 799 822
Gross margin, % 78.56 78.55 78.67 78.13 74.94 75.26 73.18 65.13 68.28 68.83
EBT 19 36 23 (27) 0 (13) (18) (149) (124) (91)
EBT margin, % 4.64 8.39 5.05 (5.88) (0.09) (2.91) (3.84) (19.91) (15.49) (11.04)
Net income 3 6 14 (28) 3 (38) (20) (151) (126) (92)
Depreciation 22 22 20 28 34 45 32 97 88 83
Per share, $
Per share, $ Revenue 22.59 23.95 24.50 24.33 21.10 23.59 22.97 20.33 20.97 20.76
Earnings 0.17 0.34 0.73 (1.51) 0.13 (1.95) (0.98) (4.12) (3.30) (2.33)
Cash flow 3.26 2.15 2.70 1.69 3.85 0.94 (0.58) (1.25) 0.68 0.84
Capex (1.01) (0.91) (0.90) (1.09) (1.26) (0.99) (1.15) (1.69) (0.91) (0.87)
Free cash flow 2.25 1.24 1.80 0.61 2.59 (0.06) (1.73) (2.94) (0.24) (0.03)
Book value 14.52 16.37 18.14 17.33 18.52 17.11 16.80 16.30 13.19 11.36
Shares, m 18 18 18 19 19 20 20 37 38 40
Valuation, ×
Valuation, × P/E 209.00 160.41 71.90 0.00 330.62 0.00 0.00 0.00 0.00 0.00
P/S 1.57 2.28 2.14 1.90 2.04 1.32 0.93 0.65 0.83 0.73
P/B 2.45 3.33 2.89 2.66 2.32 1.82 1.27 0.81 1.32 1.33
EV/Sales 1.49 2.14 2.03 1.79 1.86 1.18 0.87 0.75 0.95 0.85
EV/FCF 15.72 49.20 29.11 82.69 15.65 (187.64) (10.83) (5.06) (66.79) (193.86)
Cash, $m
Cash, $m Operating cash flow 59 39 50 32 74 18 (12) (46) 26 33
Capex (18) (16) (17) (21) (24) (20) (23) (62) (35) (35)
Free cash flow 41 22 33 12 50 (1) (35) (108) (9) (1)
Balance, $m
Balance, $m Working capital 111 172 159 176 166 164 172 255 265 246
Total debt — — — 23 25 24 22 113 175 174
Net debt (54) (81) (72) (48) (72) (64) (29) 75 89 89
Shareholders’ equity 263 297 335 328 357 337 337 599 503 450
Returns, %
Returns, % ROA 0.79 1.60 3.17 (5.92) 0.49 (7.66) (4.22) (21.88) (13.86) (10.57)
ROIC 6.28 11.84 7.15 (4.19) (1.37) (1.90) (2.70) (12.90) (8.93) (9.44)
ROE 1.10 2.22 4.37 (8.59) 0.74 (11.06) (5.86) (32.36) (22.87) (19.34)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

ORTHOFIX MEDICAL INC. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BWAY Brainsway Ltd. Sponsored ADR $475.8M 24.8× — (loss-making) +35.43% (above 0%: growing) +40.00% (above 0%: growing) −51.68% (below 0%: shrinking) 74.62% 13.98% Compare
CERS Cerus Corporation $455.5M — (loss-making) — (loss-making) +5.28% (above 0%: growing) n/m −20.90% (below 0%: shrinking) 55.91% (2.94%) Compare
NPCE NeuroPace, Inc. $438.7M — (loss-making) — (loss-making) +17.05% (above 0%: growing) n/m −78.70% (below 0%: shrinking) 82.83% (22.53%) Compare
SENS Senseonics Holdings, Inc. $435.2M — (loss-making) — (loss-making) +117.82% (above 0%: growing) n/m −223.24% (below 0%: shrinking) 59.10% (248.48%) Compare
OFIX ORTHOFIX MEDICAL INC. $390.6M — (loss-making) — (loss-making) +3.85% (above 0%: growing) n/m −516.58% (below 0%: shrinking) 70.97% (3.86%)
SI Shoulder Innovations, Inc. $382.4M — (loss-making) — (loss-making) +55.95% (above 0%: growing) n/m −52.42% (below 0%: shrinking) 78.26% (58.43%) Compare
VMD Viemed Healthcare, Inc. $371.4M 24.9× 21.9× +23.85% (above 0%: growing) −12.50% (below 0%: shrinking) −18.15% (below 0%: shrinking) 57.68% 6.39% Compare
CV CapsoVision, Inc. $343.2M 2.1× — (loss-making) +9.89% (above 0%: growing) n/m −84.44% (below 0%: shrinking) 51.36% (208.07%) Compare
RCEL Avita Medical Inc. $333.1M — (loss-making) — (loss-making) +17.83% (above 0%: growing) n/m +66.52% (above 0%: growing) 81.87% (28.42%) Compare
Median of peers $408.8M 24.8× — +20.84% — −52.05% 66.86% (25.48%)

All 149 Medical Devices stocks →

ORTHOFIX MEDICAL INC. (OFIX) key facts

  • Concern: ORTHOFIX MEDICAL INC. reported a net loss of $92.2 million, or a loss of $2.33 per share, for fiscal 2025.
  • Strength: ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024.
  • ORTHOFIX MEDICAL INC. (OFIX) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, OFIX traded at $9.38, a market capitalization of $390.6 million.
  • Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.5× sales.
  • Return on equity was −19.3% and debt-to-equity 0.55.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.29 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

ORTHOFIX MEDICAL INC. (OFIX) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/OFIX · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com